Sodium-potassium ATPase enzyme (Na+/K+-ATPase)

The Sodium-potassium ATPase enzyme (Na+/K+-ATPase) is an electrogenic membrane pump found in all animal cells, essential for maintaining high intracellular potassium and low intracellular sodium concentrations by actively transporting three sodium ions out and two potassium ions in, using energy from ATP hydrolysis. Beyond its pivotal role in establishing ion gradients and cell electrical potential, Na+/K+-ATPase functions as a signaling molecule, especially when targeted by substances like cardiac glycosides (e.g., ouabain), which can trigger pathways affecting cell proliferation, adhesion, and apoptosis. It has multiple isoforms with tissue-specific functions, and its activity is tightly regulated; faulty regulation or mutation can contribute to diverse pathologies including cardiovascular, metabolic, and neurodegenerative diseases. Its modulation has therapeutic relevance but is associated with safety risks, especially when inhibited chronically as with heart failure drugs.

Other names

Sodium-potassium pumpNa+/K+ pumpSodium-potassium ATPaseNKAEC 3.6.3.9

Inhibitors (cardiac glycosides) block the enzyme, raising intracellular sodium and calcium, which increases heart contractility but carries arrhythmia risk. Activators (e.g., insulin, β adrenergic agents) increase pump number/activity, improving potassium reuptake and membrane polarization. Antibodies/gene therapy/activators (experimental, enhance NKA activity for metabolic/cardioprotective effects)